-
In this study of surgical ICU patients in whom chest tubes were placed percutaneously for pneumothorax or sterile pleural effusion, 21% of the tubes were found on chest CT to be in a fissure, and another 9% were intraparenchymal. Only a minority of the malpositions were described in the official radiology reports.
-
-
"You should've bought it when you saw it."
-
There is no doubt concerning what was the "blockbuster" news out of this year's Congress of the European Society of Cardiology (Sophia Antipolis, France) in Vienna earlier this month. Drug-eluting stent (DES) devices are safe.
-
This year's annual meeting of the European Society of Cardiology provided the platform for unveiling the High Risk Plaque (HRP) BioImage Study to explore methods for detecting subclinical atherothrombosis disease.
-
Cardiologists in the UK are fighting an effort by the government to block coverage of drug-eluting stents (DES) in the wake of safety concerns reported over the past year.
-
Edwards Lifesciences (Irvine, California) in early September, the world leader in the science of tissue valves, reported receiving CE mark approval for its SAPIEN transcatheter aortic heart valve technology with the RetroFlex transfemoral delivery system.
-
Three years after winning FDA clearance for its original Merci Retriever — the first medical device cleared by the agency to remove blood clots from the brain in patients experiencing an ischemic stroke —Concentric Medical (Mountain View, California) reported that it has obtained FDA approval its Merci L6 Retriever.
-
AGA has received FDA approval of its occlusive device for closing a muscular ventricular septal defect (VSD) and so can now offer this therapeutic alternative to U.S. doctors and their patients.
-
